Asarina Pharma is developing novel and targeted products to treat women with severe symptoms associated with the menstrual cycle such as premenstrual dysphoric disorder (PMDD), allowing these women to remain in control of their own life.
Location: Sweden, Botkyrka kommun
Member count: 1-10
Total raised: $7.731816M
Founded date: 2006
Investors 2
Date | Name | Website |
- | Idinvest P... | idinvest.c... |
- | Kurma Part... | kurmapartn... |
Funding Rounds 1
Date | Series | Amount | Investors | Deal News |
07.11.2016 | - | $7.731816M | - | finsmes.co... |
Mentions in press and media 16
Date | Title | Description | Category | Author | Source |
05.09.2022 | Asarina Ph... | Asarina Pharma AB: new US CDC ... | - | - | news.cisio... |
25.08.2022 | Asarina Ph... | Asarina Pharma AB (publ) Q2 20... | - | - | news.cisio... |
25.05.2022 | Asarina Ph... | Asarina Pharma AB (publ) Q1 20... | - | - | news.cisio... |
06.04.2022 | ASARINA PH... | ASARINA PHARMA AB (publ) ANNUA... | - | - | news.cisio... |
24.02.2022 | Asarina Ph... | Asarina Pharma AB (publ) Year-... | - | - | news.cisio... |
16.02.2022 | First pati... | First patient in for landmark ... | - | - | news.cisio... |
22.12.2021 | Asarina Ph... | Asarina Pharma receives final ... | - | - | news.cisio... |
25.11.2021 | Asarina Ph... | Asarina Pharma AB (publ) Q3 Re... | - | - | news.cisio... |
28.09.2021 | PMDD Phase... | PMDD Phase IIb study, includin... | - | - | news.cisio... |
16.09.2021 | Administra... | Administrative backlog at publ... | - | - | news.cisio... |
Show more